BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38072378)

  • 1. Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study.
    Choffat D; Rossel JB; Aujesky D; Vollenweider P; Baumgartner C; Méan M
    J Thromb Haemost; 2024 Mar; 22(3):765-774. PubMed ID: 38072378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.
    Kamphuisen PW; Lee AYY; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    J Thromb Haemost; 2018 Jun; 16(6):1069-1077. PubMed ID: 29573330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum pharmacologic thromboprophylaxis and complications in a US cohort.
    Bruno AM; Sandoval GJ; Hughes BL; Grobman WA; Saade GR; Manuck TA; Longo M; Metz TD; Simhan HN; Rouse DJ; Mendez-Figueroa H; Gyamfi-Bannerman C; Bailit JL; Costantine MM; Sehdev HM; Tita ATN;
    Am J Obstet Gynecol; 2024 Jul; 231(1):128.e1-128.e11. PubMed ID: 38346912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort.
    Marando M; Blondon K; Darbellay Farhoumand P; Nendaz M; Grauser D; Sallet A; Tamburello A; Pons M; Righini M; Gianella P; Blondon M
    Swiss Med Wkly; 2023 Nov; 153():40117. PubMed ID: 37956238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.
    Laporte S; Chapelle C; Bertoletti L; Ollier E; Zufferey P; Lega JC; Merah A; Décousus H; Schulman S; Meyer G; Cucherat M; Mismetti P
    J Thromb Haemost; 2017 Aug; 15(8):1547-1558. PubMed ID: 28544422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
    Shalhoub J; Lawton R; Hudson J; Baker C; Bradbury A; Dhillon K; Everington T; Gohel MS; Hamady Z; Hunt BJ; Stansby G; Warwick D; Norrie J; Davies AH
    Health Technol Assess; 2020 Dec; 24(69):1-80. PubMed ID: 33275096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in-hospital bleeding in acutely ill medical patients: External validation of the IMPROVE bleeding risk score.
    Villiger R; Julliard P; Darbellay Farhoumand P; Choffat D; Tritschler T; Stalder O; Rossel JB; Aujesky D; Méan M; Baumgartner C
    Thromb Res; 2023 Oct; 230():37-44. PubMed ID: 37634309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bleeding in chronic liver disease and coagulopathy using the IMPROVE bleeding criteria.
    Chamoun N; Ramia E; Lteif C; Salameh P; Zantout H; Ghanem G; Chatila R
    Curr Med Res Opin; 2019 Mar; 35(3):427-433. PubMed ID: 30221541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.
    Häfliger E; Kopp B; Darbellay Farhoumand P; Choffat D; Rossel JB; Reny JL; Aujesky D; Méan M; Baumgartner C
    JAMA Netw Open; 2024 May; 7(5):e249980. PubMed ID: 38728035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
    Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
    J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.
    Novo-Veleiro I; Alvela-Suárez L; Costa-Grille A; Suárez-Dono J; Ferrón-Vidan F; Pose-Reino A
    BMJ Open; 2018 May; 8(5):e021288. PubMed ID: 29764885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding.
    Intagliata NM; Henry ZH; Shah N; Lisman T; Caldwell SH; Northup PG
    Liver Int; 2014 Jan; 34(1):26-32. PubMed ID: 23758818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of High-Dose Unfractionated Heparin Versus High-Dose Enoxaparin for Venous Thromboembolism Prevention in Morbidly Obese Hospitalized Patients.
    Mason SW; Barber A; Jones E; Chen SL; Moll S; Northam K
    Am J Med; 2020 Jun; 133(6):e249-e259. PubMed ID: 31862336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: where is the evidence?
    Greig MF; Rochow SB; Crilly MA; Mangoni AA
    Age Ageing; 2013 Jul; 42(4):428-34. PubMed ID: 23557678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Spirk D; Nendaz M; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Righini M; Bounameaux H; Kucher N
    Thromb Haemost; 2015 May; 113(5):1127-34. PubMed ID: 25608607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer.
    Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C
    J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronic Alerts, Comparative Practitioner Metrics, and Education Improves Thromboprophylaxis and Reduces Thrombosis.
    Woller SC; Stevens SM; Evans RS; Wray DG; Christensen JC; Aston VT; Wayne MH; Lloyd JF; Wilson EL; Elliott CG
    Am J Med; 2016 Oct; 129(10):1124.e17-26. PubMed ID: 27288858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.